Clarity is developing multisensory stimulation treatments using synchronized audiovisual pulses of light and sound to address cognitive decline in Alzheimer's and other neurodegenerative diseases. Their non-invasive approach aims to improve memory, sleep, and overall quality of life for patients while being accessible from home under professional guidance.
Funding
Funding not disclosed
Founders
Product
Problem
Alzheimer's and other neurodegenerative diseases cause cognitive decline, impacting memory, sleep, and overall quality of life. Traditional healthcare systems often fall short in providing accessible and effective solutions for managing these conditions.
Solution
Clarity is developing non-invasive multisensory stimulation treatments that use synchronized audiovisual pulses of light and sound to address cognitive decline. Their approach leverages the brain's natural tendency to follow these pulses, potentially slowing down the progression of Alzheimer's and other neurological conditions. The sensory stimulation device and associated platform are designed to be accessible from home, with professional guidance from medical experts, offering a safer alternative to current drugs.
Target Audience
The primary target audience includes individuals with Alzheimer's and other neurodegenerative diseases, as well as their loved ones and medical professionals seeking alternative therapeutic interventions.
Features
- Synchronized audiovisual stimulation using pulses of light and sound.
- Non-invasive therapeutic approach.
- Designed for home use with professional guidance.
- Potential to slow down cognitive decline.
- Aims to improve memory, sleep, and quality of life.